News
June 21 (Reuters) - The U.S. Food and Drug Administration has approved Bristol Myers Squibb's (BMY.N), opens ... to buy Mirati," Morningstar analyst Damien Conover said. He estimates just over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results